Stability of fecal calprotectin extracts using the Diasorin^® kit

Clin Chem Lab Med. 2023 Jul 20;62(1):e13-e15. doi: 10.1515/cclm-2023-0472. Print 2024 Jan 26.

Authors

Blandine Billet^{1

2}, Luc Choisnard², Patrice Faure^{1

2}, Denis Guicherd¹, Elodie Cussigh¹, Eric Peyrin², Corinne Ravelet², Benoit Chovelon^{1

2}

Affiliations

¹ Unit of Biochemistry of Hormones and Nutrition, Institute of Biology and Pathology, Grenoble Alpes University Hospital, Grenoble, France.
² DPM UMR 5063, University Grenoble Alpes, CNRS, Grenoble, France.

PMID: 37470268
DOI: 10.1515/cclm-2023-0472

No abstract available

Keywords: Diasorin®; fecal calprotectin; pre-analytical conditions; stool samples.

Publication types

Letter

MeSH terms

Biomarkers
Feces
Humans
Inflammatory Bowel Diseases*
Leukocyte L1 Antigen Complex*

Substances

Leukocyte L1 Antigen Complex
Biomarkers